It is intriguing that the inhibitory effects of EGFR tyrosine kinase inhibitor AG1478 on cell proliferation were more effective in β1-KO cells than in WT cells, which suggested that a treatment combining anti-EGFR therapy with anti-integrin drugs wound be important for cancer therapy. The gene discussed is EGFR; the disease is cancer.